Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Novartis patent term dabrafenib?Does lipitor's effectiveness decrease with high fat meals?Can grapefruit consumption affect lipitor's efficacy?Symbravo medication information ema europa eu?Pramlintide approval date?
See the DrugPatentWatch profile for nayzilam
Nayzilam (midazolam nasal spray) is an FDA-approved rescue treatment for seizure clusters—multiple seizures occurring close together—in adults and children 12+ weighing at least 88 pounds. It's not for ongoing epilepsy management but for stopping acute clusters lasting 5+ minutes or when seizures repeat rapidly. Administer only during a witnessed seizure cluster; do not use prophylactically.[1]
Effects start in 10 minutes, peaking at 1 hour, lasting 1-2 hours. It calms brain activity to halt seizures but causes sedation or sleep. Call emergency services if: - Seizure lasts >10 minutes after second dose. - Breathing slows/stops. - No response after 10 minutes. Do not give more than two doses in 12 hours.[1]
| Treatment | Form | Onset | Dosing Limit | Key Edge | |-----------|------|--------|--------------|----------| | Nayzilam | Nasal spray | 10 min | 2 doses/12 hrs | Hands-free, no needles | | Diastat (diazepam) | Rectal gel | 10-15 min | 1 dose/5 days | Works in kids <12 | | Valtoco (diazepam) | Nasal spray | 10 min | 2 doses/24 hrs | Similar but different formulation | Nayzilam avoids rectal route, suiting public use.[2]
Require prescription and hands-on training from a doctor. For frequent clusters, discuss long-term options like preventive anti-seizure drugs. Track use in a seizure diary for your neurologist.[1] [1]: Nayzilam Prescribing Information (UCB) [2]: Epilepsy Foundation: Nayzilam Guide [3]: FDA Nayzilam Label
Other Questions About Nayzilam :